Download 1 - University of Miami

Curriculum Vitae
1.
Sept. 30, 2014.
I. PERSONAL
2.
Name
:
Subbarayan R Pochi
3.
Office Phone number :
305-243-4887
4.
Current Academic Rank
:
Research Assistant Professor
5.
Current Track of Appointment
:
Research track
6.
Primary Department
:
Medicine
7.
Secondary or Joint Departmental Appointments
:
Nil
8.
Division
:
Hematology & Oncology
9.
Citizenship
:
USA & Overseas Citizen of India (OCI)
10.
Visa Type
:
Citizen
II. HIGHER EDUCATION
11. Institutional
:
M.Sc. University of Madras, June 1988.
Ph.D., Banaras Hindu University, April 1994.
12. Non-Institutional
:
Nil
13. Certification, Licensure :
CITI certification - Current.
“Translational Research Boot camp’ conducted by the CTSI” Sept. 10-14, 2012.
III. EXPERIENCE
14. Academic:
University of Miami Miller School of Medicine;
Research Assistant Professor,
Excelsior College Online
Adjunct Faculty
Kaplan University Online
Adjunct Faculty
Miami Dade College, Miami, FL
Adjunct Faculty
University of Miami Miller School of Medicine
Assistant Scientist
University of Miami Miller School of Medicine
Postdoctoral Research Associate
National Institute of Genetics, Mishima, Japan
Researcher
National Institute of Health, Tokyo, Japan
STA Fellow
Center for Cellular & Molecular Biology, India
Postdoctoral Fellow
15. Hospital
:
Nil
16. Non-Academic :
Nil
17. Military
:
Nil
Since Oct. 2007
2008 - 2012
2007 - 2008
2005 – 2008
2002 – 2007
1999
2002
1997 – 1998
1995 – 1996
1994 – 1995
1
IV. PUBLICATIONS:
18. Books and monographs published
1.
Subbarayan PR*, Braunschweiger P and Ardalan B, Inhibition of RNA synthesis by 5fluorouridine accounts for its cyto toxicity on colorectal cancer cells in vitro In: New Messenger
RNA Research Communications, Kwang LB Ed., Nova Science Publishers, Inc. 99-111, 2007.
19. Referred Journal articles (*Corresponding author)
2.
Subbarayan PR*, Ardalan B. In the war against solid tumors arsenic trioxide need partners, J
Gastrointest Canc, 45(3):363-371, 2014 (10.1007/s12029-014-9617-8).
3.
Subbarayan PR*, Sarkar M, Nathanson L, Doshi N, Lokeshwar B, Ardalan B. In vitro global
gene expression analyses support the ethno-pharmacological use of Achyranthes aspera, Evid
Based Complementary Altern Med. Volume 2013, Article ID 471739, 13 pages, 2013
http://dx.doi.org/10.1155/2013/471739.
4.
Subbarayan PR*, Sarkar M, NagarajaRao S, Philip S, Kumar P, Altman N, Reis I, Ahmed M,
Ardalan B, Lokeshwar B. Achyranthes aspera (Apamarg) Leaf extract inhibits human pancreatic
tumor growth in athymic mice by apoptosis, J. Ethnopharmacology, 142: 523-530, 2012.
5.
Hammad H, Sarkar M, Subbarayan PR*, Ardalan B, Thymidylate synthase 5’ UTR
polymorphic allele distribution in South Florida population. Journal of Cancer Therapy, 3:173176, 2012.
6.
Hammad H, Sarkar M, Gupta N, Ardalan B, Subbarayan PR*. The presence of three repeats in
the 5' UTR region of thymidylate synthase (TS) is associated with increased TS mRNA
expression in cultured human cancer cell lines in vitro. Oncology Reports, 27(1):246-249, 2012.
7.
Paley EL, Paley DE, Merkulova-Rainon T, Subbarayan PR. Hypoxia signature of splice forms
of tryptophanyl-tRNA synthetase marks pancreatic cancer cells with distinct metastatic abilities.
Pancreas. 40(7):1043-56, 2011.
8.
Podolsky L, Oh M, Subbarayan PR, Francheschi D, Livingstone A, Ardalan B. 5-Fluorouracil/
Leucovorin and Arsenic Trioxide for Patients with Refractory/Relapsed Colorectal Carcinoma: A
Clinical Experience. Acta Oncologica, 50: 602-605, 2011.
9.
Subbarayan PR*, Sarkar M, Impellizzeri S, Raymo F, Lokeshwar BL, Kumar P, Agarwal R and
Ardalan B. Anti proliferative and anti cancer properties of Achyranthes aspera: Specific
inhibitory activity against pancreatic cancer cells and the expression of metastatic and angiogenic
promoting genes in vitro. J. Ethnopharmacology, 131: 78–82, 2010.
10. Subbarayan PR*, Sarkar M, G. Nelson G, Benitez E and Ardalan B, Chronic exposure of
colorectal cancer cells to fluoropyrimidine analogues in vitro induces thymidylate synthase and
suppresses p53. A molecular explanation for the mechanism of 5-FU resistance. Anticancer Res.
30(4): 1149-1156, 2010.
11. Subbarayan PR*, Lee K and Ardalan B, Arsenic trioxide suppresses thymidylate synthase in 5FU resistant colorectal cancer cell line HT29 (HT29FU) in vitro sensitizing them back to 5-FU.
Anticancer Res. 30(4): 1157-1162, 2010.
2
12. Ardalan B, Subbarayan PR, Ramos Y, Gonzalez M, Fernandez A, Mezentsev D, Reis I,
Duncan R, Podolsky L, Lee K, Lima M, Ganjei-Azar P, A Phase I Study of 5-FU (plus
Leucovorin) and Arsenic Trioxide for Patients with Refractory/Relapsed Metastatic Colorectal
Carcinoma, Clin Cancer Res; 16(11); 3019–27, 2010.
13. Gennaro ED, Bruzzese F, Pepe S, Leone A, Delrio P, Subbarayan PR, Avallone A and Budillon
A. Modulation of thymidylate synthase and p53 expression by HDAC inhibitor vorinostat
resulted in synergistic antitumor effect in combination with 5FU or Raltitrexed. Cancer Biology
& Therapy 8(9):782-91, 2009.
14. Subbarayan PR*, Wang PG, Lampidis TJ, Ardalan B, and Braunschweiger P, Differential
expression of Glut1 mRNA and protein levels correlates with increased sensitivity to the glycoconjugated nitric oxide donor (2-glu-SNAP) in different tumor cell types. J. Chemotherapy
20(1): 106-111, 2008.
15. Paley EL, Smelyanski L, Malinovskii V, Subbarayan PR, Berdichevsky Y, Posternak N,
Gershoni JM, Sokolova O, Denisova G, Mapping and molecular characterization of novel
monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian
Tryptophanyl-tRNA Synthetase reveal link of the epitopes to aggregation and Alzheimer's
disease. Mol Immunol. 44(4):541-557, 2007.
16. Subbarayan PR*, Lima M and Ardalan B, Arsenic trioxide/ascorbic acid therapy in patients
with refractory metastatic colorectal carcinoma: A clinical experience, Acta Oncologica
46(4):557-61, 2007.
17. Subbarayan PR* & Sarkar M, A stop codon dependent internal Secondary Translation
Initiation Region in Escherichia coli. RNA 10(9):1359-1365, 2004.
18. Subbarayan PR* & Sarkar M, Escherichia coli rpoS gene has an internal Secondary Translation
Initiation Region. Biochem.Biophys.Res.Commun 313(2): 294-299, 2004.
19. Subbarayan PR* & Sarkar M, A comparative study of variation in codon 33 of the rpoS gene in
Escherichia coli K12 stocks: implications for the synthesis of sigma(s). Mol Genet Genomics.
270(6): 533-538, 2004.
20. Gowrishankar J, Yamamoto K, Subbarayan PR & Ishihama A, Mutants of RpoS (s) of
Escherichia coli deleted for N-terminal subregion 1.1 or C-terminal region 4: in vitro properties.
J. Bacteriol. 185(8): 2673-2679, 2003.
21. Subbarayan PR*, Sarkar M & Ardalan B, Isolation of Genomic DNA from Human Whole
Blood, Biotechniques 33(6): 1231-1234, 2002.
22. Subbarayan PR & Deutscher MP, Escherichia coli RNase M is a multiply altered form of
RNase I, RNA 7: 1701-1707, 2001.
23. Subbarayan PR, Shichishima T, Yoshida H, Maruyama S & Naiki M, Report of one patient
with paroxysmal cold hemoglobinuria, Int. J. Hematol. 65: 165-167, 1997.
24. Subbarayan PR, Sarkar M & Vinayak M, Analysis of transfer RNA during the early
embryogenesis of the freshwater teleost, Heteropneustes fossilis, Mol. Biol. Rep. 21(2): 113-118,
1995.
25. Subbarayan PR & Vinayak M, Improvement in the quality of milt of Heteropneustes fossilis, J
Sci. Ind. Res. 44: 23-26, 1995.
3
26. Sarkar M, Subbarayan PR & Vinayak M, Transfer RNA analysis during the reproductive cycle
of a freshwater teleost, Heteropneustes fossilis, Mol. Biol. Rep. 20(1): 9-14, 1994.
20. Other works, Publications and abstracts:
Conference Proceedings
27. Sarkar M, Subbarayan PR, Philip S, Kumar P, Ahmed M, Ardalan B, Lokeshwar B (2012).
Systematic analyses validates in vitro and in vivo anticancer properties of the Ayurvedic plant
Achyranthes aspera, Planta Medica 78(11): 1182 (PI167).
28. Subbarayan PR, Sarkar M, Philip S, Kumar P, Ahmed M, Ardalan B, Lokeshwar B (2012).
From Bedside to Bench: Characterization of in vitro and in vivo anticancer properties of
Achyranthes aspera (Apamarg) Leaf extract. Biomedical Papers 156(1): S21 O-30.
29. Jin X, Zimmers TA, Subbarayan PR, Zhanga Z, Ardalan A and G. Koniaris LG (2008), QS61.
IL-6 Is An Essential Inhibitor of Apoptosis Following Intestinal Injury. J. Surg. Res. 144 (2):
293.
30. L. Paley, V. Malinovskii, S.R. Pochi, B. Ardalan and T.J. Lampidis (2004), Hypoxia inducible
transcriptional factor-1a is associated with mitosis under normoxia and hypoxia. The Miami
Nature Biotechnology winter symposia, Miami, Fl, USA.
(http://www.med.miami.edu/mnbws/Malinovskii-.pdf).
31. Subbarayan PR*, M. Sarkar, G. Nelson, E. Benitez and B. Ardalan (2004), Cyclin B1 mediated
G2/M DNA damage checkpoint is affected in 5FU resistant colorectal cancer HT29 cells. The
Miami Nature Biotechnology winter symposia, Miami, Fl, USA.
(http://www.med.miami.edu/mnbws/Pochi-.pdf).
Abstracts
32. Subbarayan PR*, Sarkar M, Nathanson L, Doshi N, Lokeshwar B, Ardalan B. In vitro global
gene expression analyses support the medicinal use of Achyranthes aspera. Evaluating Bioactive
Food Components in Obesity and Cancer Prevention, September 27-29, 2013, Fort Walton
Beach, FL, USA.
33. Subbarayan PR, Sarkar M, Lokeshwar B, Ardalan B. Systematic investigations of the anti
cancer properties of the medicinal plant Achyranthes aspera. GRC Conference, “Natural
Products.” July 28 – Augurst 2, 2013, Andover NH, USA.
34. Subbarayan PR, Sarkar M, NagarajaRao S, Pilip S, Kumar P, Ahmed M, Ardalan B,
Lokeshwar B. Achyranthes aspera (Apamarg) Leaf extract is preferentially cytotoxic to
pancreatic cancer cells in vitro and inhibits human pancreatic tumor growth in athymic mice by
apoptosis; 13th Annual Zubrod Memorial Lecture and Sylvester Cancer Research Poster Session;
May 18, 2012, Miami, FL, USA.
35. Kumar P, Subbarayan PR, Sarkar M, NagarajaRao S, Pilip S, Altman N, Ahmed M, Ardalan B,
Lokeshwar B. Anticancer Activity of Achyranthes aspera (Apamarg); International Conference
on Cancer Prevention, Diagnosis & Treatment, January 21-22, 2012, Jaipur, INDIA.
36. Subbarayan PR, Ramos Y, Fernandez A, Gonzalez M, Mezentsev D, Bongato T, Ganjei-Azar
P, Reis I, Lee K, Ardalan B (2009), Phase I study of escalating doses of 5-FU and Arsenic
Trioxide (As2O3) in patients with refractory metastatic colorectal carcinoma, American
Association for Cancer Research 100th Annual Meeting, April 18-22, 2009, Denver, CO, USA.
4
37. Hammad H, Subbarayan PR and Ardalan B (2008), 5’ and 3’ polymorphic region of the TS
gene as a prognostic marker in 5FU based chemotherapy, American Association for Cancer
Research 99th Annual Meeting, April 12-16, 2008, San Diego, CA, USA.
38. S. R. Pochi, R. Yipsel, D. Mezentsev, P. Ganjei-Azar, I. Reis, K. Lee, B. Ardalan (2008), A
continued report on phase I study of escalating doses of 5-FU and arsenic trioxide (As2O3) in
patients with refractory metastatic colorectal carcinoma, 2008 Gastrointestinal Cancers
Symposium, ASCO-GI, Jan. 2008, Orlando, FL, USA.
39. Subbarayan PR, Sarkar M, Nelson G, Benitez E and Ardalan B (2007), Chronic exposure of
CRC cell line HT29 to 5-FU or FUR alters multiple independent pathways, American
Association for Cancer Research 98th Annual Meeting, April 14-18, 2007, Los Angeles, CA,
USA.
40. Subbarayan PR, Ramos Y, Mezentsev D, Bongato T, Ganjei-Azar P, Reis I, Kozyreva O, Lee
K, Ardalan B (2007), A Phase I study of 5-FU and arsenic trioxide for patients with refractory
metastatic colorectal carcinoma, 2007 Gastrointestinal Cancers Symposium, ASCO-GI, Jan.1921, 2007, Orlando, FL, USA.
41. Subbarayan PR, Lee P and Ardalan B (2005), Inhibition of RNA synthesis by 5-fluorouridine
accounts for its cyto toxicity on colorectal cancer cells in vitro, American Association for Cancer
Research 96th Annual Meeting, April 16-20, 2005, Anaheim, CA, USA.
42. Subbarayan PR, Wang PG, Lampidis TJ, Ardalan B and Braunschweiger P (2005). Increased
expression of Glut1 mRNA and protein levels correlates with increased sensitivity to glycolconjugated nitric oxide donors in different cell types, American Association for Cancer Research
96th Annual Meeting, April 16-20, 2005, Anaheim, CA, USA.
43. Subbarayan PR, Sarkar M, Nelson G, Shabashvili D & Ardalan B (2004), Akt1/PKB pathway
is affected in 5-FU resistant HT-29 cells. American Association for Cancer Research 95th Annual
Meeting, March 27-31, 2004, Orlando, Fl, USA.
44. Maher JC, Priebe S, Savaraj N, Paley E, Liu H, Subbarayan PR & Lampidis TJ (2004),
Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with
GLUT 1 expression. American Association for Cancer Research 95th Annual Meeting, March
27-31, 2004, Orlando, Fl, USA.
45. Subbarayan PR, Sarkar M, & Vinayak M (1994), The initiation of RNA and protein synthesis
in Heteropneustes fossilis, Ann. Meetings of the American Association for the Advancement of
Science, Feb. 18-23, 1994, San Francisco, USA.
46. Subbarayan PR, Sarkar M & Vinayak M (1994), Onset of embryonic transcription in the
freshwater teleost, Heteropneustes fossilis, XVI IUBMB, Sept. 19-22, 1994, New Delhi, India.
47. Vinayak M, Sarkar M & Subbarayan PR (1994), Accumulation of tRNA in ovary during
reproductive cycle of a freshwater teleost, Heteropneustes fossilis, XVI IUBMB, Sept. 19-22,
1994, New Delhi, India.
48. Abdulla A, Subbarayan PR & Ardalan A (2002), Standardization of a strategy to analyse
tandem repeats in the 5'UTR of hTS gene, University of Miami, Department of Biology
Undergraduate Research Seminar, Coral Cables, Fl, USA.
5
49. Subbarayan PR, Sarkar M & Vinayak M (1993), Studies of RNA & protein synthesis during
embryonic development of Heteropneustes fossilis, 62nd Ann. Gen. Body Meetings of the
Society of Biological Chemists (India), Dec. 19-22, 1993, Madurai, India.
50. Sarkar M, Subbarayan PR & Vinayak M (1993), Analysis of tRNA during ovarian cycle of
Heteropneustes fossilis, XVI All India Cell Biology Conference and Symposium, Jan. 1-3, 1993,
Varanasi, India.
51. Subbarayan PR, Sarkar M & Vinayak M (1992), tRNA studies in preparatory phase of a
freshwater teleost, Heteropneustes fossilis, 61st Ann. Gen. Body Meeting of the Society of
Biological Chemists (India), Dec. 21-23, 1992, Hyderabad, India.
52. Sarkar M, Subbarayan PR & Vinayak M (1992), Quantitative and qualitative analysis of tRNA
from ovary, male & female liver during preparatory phase of a teleost, 6th National Conference
of AGI, Nov. 17-19, 1992, Aligarh, India.
21. Other works accepted for publication:
53. Block K, …, Subbarayan PR et. al. A Broad-Spectrum Integrative Design for Cancer Therapy,
Seminars in Cancer Biology. 2014.
54. Jiang WG, Sanders AJ, Katoh M, Ungefroren H, Gieseler F, Prince M, Thompson S, Zollo Mf,
Spano D, Dhawan P, Sliva D, Subbarayan RP, Sarkar M, Honoki K, Fujii H, Georgakilas A,
Amedei A, Niccolao E, Amin A, Ashraf SS, Ye La, Helferich B, Yang X, Boosani CS, Guha G,
Ciriolo MR, Aquilano K, Chen S, Azmi AS, Keith WN, Bilsland A, Bhakta D, Halicka D,
Nowsheen S, Pantano F, Santini D. Tissue Invasion and Metastasis: Molecular, Biological and
Clinical Perspectives, Seminars in Cancer Biology. 2014.
55. Subbarayan PR. Impact and challenges of Chemoinformatics in drug discovery. In: Artificial
Neural Network for Drug Design, Delivery and Disposition. Ed. Pathak Y. Puri M, Sutariya VK,
Tipparaju S and Moreno W. (2015).
56. Subbarayan PR*, Doshi N, Wang Z, Robbins D, Capobianco T, Ardalan. B Computational
motif analyses confirm the presence of Gli consensus sequence in thymidylate synthase
transcriptional regulatory region (Communicated).
V. PROFESSIONAL
22. Funded Research Performed:
Pre-doctoral Fellowship:
Junior Research Fellow, University Grants Commission, India – 1988 - 1992
Senior Research Fellow, University Grants Commission, India – 1992 - 1994
Role: STA Fellow
Effort: 100%
Mentor: Dr. Masaharu Naiki, National Institute of Health, Tokyo, Japan.
STA Postdoctoral Fellowship, Science & Technology Agency, Japan
Title: Cloning and characterization of fimbrial antigen in ETEC K99
1995-1996
6
CREST
Role: Researcher
Effort: 100%
1997-1998
Title: Determination of the Hierarchy of Gene Expression. Project of the Core Research for
Evolutional Science and Technology (CREST), Japan Science and Technology Corporation,
Japan,
PI: Dr. Akira Ishihama, National Institute of Genetics, Mishima, Japan
Project Objective: To elucidate the stationary phase phenomenon in Escherichia coli and to
unravel the mechanism of stationary phase regulation by rpoS gene.
Sylvester SCCC 2003073
Role: Investigator
Effort: 100%
2004 - 2006
PI: Dr. Bach Ardalan MD
Title: Basic Science Research Model for Gastrointestinal Cancers
5FU or FUdR is used as a standard chemotherapy agent to treat colorectal cancer patients.
However, the efficacy has been linked to thymidylate synthase expression. In this study we
collect blood and tissue samples from the patients undergoing treatment and monitor the TS
profile. My role in this project is investigator.
NIH R21 1R21CA117116-01A2
Role: Investigator
Effort: 100%
June 2007 to May 2009
PI: Dr. Bach Ardalan MD
Title: Reversal of 5-FU resistance by arsenic trioxide in colorectal carcinoma
It is a Phase I clinical trial. The enrolled patients receive a combination of arsenic trioxide
and 5FU/Leucovorin. As a co-PI, I help to investigate the role of arsenic trioxide in regulating
thymidylate synthase (TS) gene expression in the peripheral blood and tumor tissues of the study
participants. As a collaborator my role in this project is to manage the basic research aspects of
this Phase I clinical trial.
NIH R25: 5R25GM050083-06
Role: Collaborator
Sept. 1996 to March 2008
Role: Mentor for UM-MDC bridge scholars. Under this program I have trained about 10
minority scholars.
PI: Dr. Michael Gaines
Title: Miami-Dade College - University of Miami Bridge Program
It is an innovative program to motivate, recruit and retain freshman scholars to do biology
research and to attract students to Ph.D. programs and research careers. Essentially these students
are matched with UM researcher to work in their laboratories.
NIH 5R25GM076419-02
March 2006 to March 2010
Role: Mentor for IMSD scholars
PI: Dr. Michael Gaines
Project Title: Initiative for Minority Student Development / Increasing Minority Student
Diversity (IMSD).
The goal is to support underrepresented minorities in graduate programs in the biomedical
sciences through fellowships.
7
American Cancer Society (ACS), Institutional Research Grant (2010) Nov. 2010 – October 2011
Role: PI
Project Title: Identification of anticancer agent(s) from the plant Achyranthes aspera
The goal of this project is 1. to investigate the in vivo anti tumor activity of methanol extract of
the leaves of A. aspera, 2. chemical identification and purification of the active antic cancer agent in
this preparation.
IDRI Grant #102504
08/01/11 – 05/31/13
Role: PI
Project Title: Identification of Anticancer Molecule form the Medicinal Herb Achyranthes
aspera
The goal of this project is to identification and characterization of the active molecule in LE,
elucidate the in vivo biological activity of the purified compound.
CTSI Pilot Research Grant (CTSI-2013-P03)
01/02/2013 - 05/31/2014
Role: PI
Project Title: Characterization of bioactive saponins with anticancer activity from Achyranthes
aspera
The goal of this project is to characterize the bioactive saponins in A. aspera.
NHMFL user project ML-Pochi-001
03/01/2013 – 02/29/2016
Role: PI
Project Title: Structural determination of the active anti cancer molecule in Achyranthes aspera
The goal of this project is to use multi dimensional NMR at Advanced Magnetic Resonance
Imaging and Spectroscopy Facility, National High Magnetic Field Laboratory (NHMFL) to
resolve the structure of the active anticancer molecule in A. aspera.
Grant Editing Support Award 08/01/2014 - 07/31/2015
Role: PI
Project Title: Preclinical Studies of the Cytotoxicity of Nayurvin, A Plant-derived Porphyrin
The award enables me consult paid external experts critique my grant application.
SEEDS You Choose Awards (PI: Sarkar M, Ph.D.)
01/12/2013 – 05/31/2014
Role: Collaborator
Project Title: "Investigation of Developmental Toxicity of a Newly Discovered Anticancer
Molecule 'Nayurvin' in Zebrafish (Danio rerio)"
The goal of the project is to use Zebrafish model to test the toxicity of Nayurvin. This
investigation will also prepare the basis for future undergraduate research
President’s Faculty Research and Development Grant
05/01/2014 – 04/30/2015
Role: Collaborator
(PI: Nathanson L, Ph.D.)
Project Title: Explorative gene expression and pathway analysis for innovative cancer treatment
The goal of this project is to generate preliminary data for a large cohort study
Pending Grants:
NIH R-01
Role: PI
April 2015- March 2020
Title: Preclinical studies of the cytotoxicity of Nayurvin, a plant-derived porphyrin
Bank Head Coley Research Grant
Role: PI
Feb. 2015- Jan. 2018
Title: Preclinical studies of the cytotoxicity of Nayurvin, a plant-derived porphyrin
8
SEEDS You Choose Leadership Award
Role: PI
Workshop on Clear and Concise Writing Skills for Academic Settings
2014- March 2015
23. Editorial responsibilities
Chair, Editorial Board for the Newsletter of the American Association of Indian Scientists in
Cancer Research (AAISCR) - 2007-2010.
Peer Reviewer for: Cancer, Current Pharmaceutical Design, Cancer and Anticancer Drugs, J of
Biomedicine and Biotechnology, Evidence-Based Complementary and Alternative Medicine,
Journal of Biomedicine and Biotechnology, Journal of Pharmacognosy and Phytotherapy,
African Journal of Agricultural Research, Molecular Biology Report, European Journal of
Medicinal Plants, Cancer, etc.
24. Professional and Honorary Organizations (member, officer, date)
Active member
Life Member
Life Member
Life Member
American Association for Cancer Research (USA), since 2002
American Association of Indian Scientists in Cancer Research (AAISCR)
Society of Biological Chemists (India)
Indian Association of Cancer Research (India)
25. Honors and awards: (Selected few)
Listed in Who’s is Who in Medicine and Healthcare, 5th Edition
2004
STA Fellow, Science & Technology Agency, Japan
1995
‘YOUNG SCIENTIST’ Award, International Union of Biochemistry and
Molecular Biology
1994
26. Postdoctoral Fellowships:
University of Miami Miller School of Medicine
Postdoctoral Research Associate
National Institute of Health, Tokyo, Japan
STA Fellow
Center for Cellular & Molecular Biology, India
Postdoctoral Fellow
1999 - 2002
1995 – 1996
1994 – 1995
27. Other Professional Activities:
Reviewer of Grants:
In August 2014, I was selected as a reviewer under Early Career Reviewer (ECR) program at the
Center for Scientific Review, NIH.
Resource person:
Real Time PCR dry workshop
Part of IACR conference and Symposium, Ahmadabad, Gujarat, India
Feb. 2008
Conference Session Chair:
“Natural Anticancer Drugs” (NAD), Olomouc, Czech Republic.
Indian Association for Cancer Research Conference and Symposium
Ahmadabad, Gujarat, India.
July 2, 2012.
Feb, 2008
9
Invited lectures:
“Natural Anticancer Drugs” (NAD), Olomouc, Czech Republic.
Indian Association for Cancer Research Conference and Symposium
Ahmadabad, Gujarat, India.
Banaras Hindu University, India
Center for Cellular and Molecular Biology
Indian Institute of Technology, Kharagpur, Roorky, Chennai, India
Rajiv Gandhi Center for Biotechnology, Trivandrum, India
July 2, 2012.
Feb, 2008
May 2004
June 2004
May, June 2004
June 2004
Chair - Editorial Board:
Quarterly Newsletter of the
American Association of Indian Scientist in Cancer Research (AAISCR)
2007-2010
VI. TEACHING
28. Teaching Awards received
:
Nil
29. Teaching specialization
:
I teach basic biology courses that covers various aspects of life sciences viz introductory biology,
genetics, developmental biology etc. I have been certified to teach BS degree program of the
Miami Dade College (2005). I am trained to teach online courses for Kaplan University online
and Excelsior (online) college, NY.
30. Thesis and Dissertation Advising/Postdoctoral student supervision
Undergraduate research:
Since 2002, I have mentored more than 19 undergraduates complete their research thesis.
Research work conducted by Ms. Lisa Ramsey, 2004 and Ms. Hiba Hammad, 2007 were
adjudged the best by a panel of independent judges.
1. Ms. Alia Abdulla
2. Mr. Dmitry Castillo
3. Ms. Lisa Ramsay
4. Mr. Philip Lee
5. Mr. Daniel Shabashvili
6. Mr. Nelson Hernandez
7. Mr. Grodonoff Nelson
8. Mr. Edilberto Benitez
9. Mr. Raveesh Richard
10. Ms. Yipsel Ramos
11. Ms. Hiba Hammad
12. Ms. Kareena Coronado
13. Mr. Michael Gonzalez
14. Mr. Anthony Fernandez
2002
2003
2004
2005
2005
2005
2006
2004
2005
2007
2007
2007
2008
2008
15. Eli Nehme
16. Nikhil Gupta
17. Shibani Singal
18. Nikesh Doshi
19. Ms. Nitya Ramalingam
2009
2011
2012
2013
Current
Research Interns
20. Dr. Upama Giri, MBBS
Current
High School Students
21. Samantha Agron
22. Stephanie Balepogi
23. Zoe Zhang
2010
2010
2013
VII. SERVICE
31. University Committee and Administrative Responsibilities:
Early Career Reviewer (ECR) program, Center for Scientific Review (CSR
National Institutes of Health
Member Protocol Review Committee
2014
Since 2006
10
32. Community Activities:
Volunteer School safety – Pinecrest Elementary School, Pinecrest, FL
Volunteer – MDC Medical Center Health Fair Feb. 18, 2006.
Volunteer – Miami Book Fair International
Judge – Miami-Dade County Science Fair
2003-2004
Feb. 2006
Nov. 2006
Jan. 2008
Mentor
Mentor in a special program for high school students entitled, “The Conquest of Cancer and the
Next Generation,” American Association for Cancer Research
97th AACR Annual Meeting, April 3, 2006, Washington DC.
98th AACR Annual Meeting, April 14-18, 2007, Los Angeles, CA.
Panel Member:
Associate Member Council, Grant writing workshop,
AACR Annual meetings, San Francisco.
April 2002
Member
Asian American Advisory Board (AAAB), Miami-Dade County
Since 2014
AAAB is one of the boards in the Miami-Dade County’s Office of Community Advocacy
(OCA). The AAAB serves in an advisory capacity to the County Commission, the County
administration, and all agencies and persons in Miami-Dade County.
Founder & President (2009 – 2014)
Dade BalVihar – a Sunday school to mentor children of Hindu origin
Member (Since 2005) and past President (2011) Ekal Vidyalaya Foundation USA, South
Florida Chapter. Under my leadership we raised record $160,000 in 2011
(http://www.deshvidesh.com/Current_Issue/Desh-Videsh-January-2012/ekal-vidyalayaflorida.html).
“The Ekal Vidyalaya Foundation is a tax exempt, registered non-profit service organization
dedicated to education and village development in rural India. Ekal's philosophy is to take a
holistic approach to social and economic development. The Ekal movement is the largest,
grassroots, non-government education movement in India, operating in over 54,081 villages and
educating over 1,472,991 children in rural India” - http://www.ekal.org.
***
11